TY - JOUR
T1 - Blastocyst injection of embryonic stem cells
T2 - A simple approach to Unveil mechanisms of corrections in mouse models of human disease
AU - Schneider, Joel S.
AU - Vitale, Joseph M.
AU - Terzic, Andre
AU - Fraidenraich, Diego
N1 - Funding Information:
Acknowledgments We thank Dr. Robert Benezra (Memorial Sloan-Kettering Cancer Center) for support with initial studies. This work was supported by the National Institutes of Health (D.F., A.T.), American Heart Association (D.F.), Muscular Dystrophy Association (D.F.), New Jersey Commission on Science and Technology (D. F.), UMDNJ Foundation (D.F.), American Society for Clinical Pharmacology and Therapeutics (A.T.), Marriott Heart Disease Research Program (A.T.), Marriott Foundation (A.T.), Ted Nash Long Life Foundation (A.T.), Ralph Wilson Medical Research Foundation (A.T.), and Mayo Clinic Clinician-Investigator Program (A.T.).
PY - 2009/12
Y1 - 2009/12
N2 - Embryonic stem cell (ESC) research is a promising area of investigation with enormous therapeutic potential. We have injected murine wild type (WT) ESCs into a variety of mutant murine blastocysts, which are predisposed to develop a human-like disease, such as muscular dystrophy or the embryonic lethal "thin myocardial syndrome". In this review, we summarize data indicating that partial incorporation of ESCs is sufficient to prevent disease from occurring. We also present data indicating that blastocyst incorporation of ESCs may aid in the prevention of heart failure in stressed WT mice. In some cases, the rescue observed is predominantly non-cell autonomous and relies on the production of secreted factors from the ES-derived cells, but in others, cell replacement is required. Thus, congenital or acquired disease can be pre-emptively averted in mice by developmental injection of ESCs.
AB - Embryonic stem cell (ESC) research is a promising area of investigation with enormous therapeutic potential. We have injected murine wild type (WT) ESCs into a variety of mutant murine blastocysts, which are predisposed to develop a human-like disease, such as muscular dystrophy or the embryonic lethal "thin myocardial syndrome". In this review, we summarize data indicating that partial incorporation of ESCs is sufficient to prevent disease from occurring. We also present data indicating that blastocyst incorporation of ESCs may aid in the prevention of heart failure in stressed WT mice. In some cases, the rescue observed is predominantly non-cell autonomous and relies on the production of secreted factors from the ES-derived cells, but in others, cell replacement is required. Thus, congenital or acquired disease can be pre-emptively averted in mice by developmental injection of ESCs.
KW - Blastocyst
KW - Congenital heart disease
KW - Embryonic stem cells
KW - Mouse model of human disease
KW - Muscular dystrophy
KW - Myocardial infarction
UR - http://www.scopus.com/inward/record.url?scp=74649086642&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=74649086642&partnerID=8YFLogxK
U2 - 10.1007/s12015-009-9089-6
DO - 10.1007/s12015-009-9089-6
M3 - Article
C2 - 19705303
AN - SCOPUS:74649086642
SN - 1550-8943
VL - 5
SP - 369
EP - 377
JO - Stem Cell Reviews and Reports
JF - Stem Cell Reviews and Reports
IS - 4
ER -